Piramal Group

Piramal Group, founded in 1947, is a diversified global business conglomerate operating across the pharmaceutical, financial services, and real estate sectors. The organization leverages a sophisticated technology platform integrated with artificial intelligence to deliver innovative solutions across multiple industry verticals. By focusing on high-growth areas such as retail lending, wholesale lending, and fund-based platforms, the company maintains a robust market presence. Their pharmaceutical division provides comprehensive end-to-end contract development and manufacturing services, supporting complex drug life cycles and global healthcare networks.

The company operates at a significant scale, employing 10,000-15,000 employees across 15 global locations. This operational footprint enables the delivery of specialized services, including anesthesia, pain management, and advanced diagnostic analytics. Meet Piramal Group's team to learn about the leadership driving these diverse business units and their commitment to operational excellence. The firm’s strategic focus on digital transformation and data-driven decision-making ensures they remain competitive in rapidly evolving markets.

Financially, Piramal Group demonstrates strong performance with annual revenue reaching $1.2B. The company has successfully secured significant capital, including a $493.3M private equity investment from The Carlyle Group in 2020 and a $200.0M funding round in 2024. These investments underscore investor confidence in their long-term growth strategy and diversified business model. Explore financial highlights for detailed metrics regarding their fiscal performance and capital structure. This combination of historical stability and modern innovation positions the group as a key player in the global economy.